ACX Therapeutics Analysis
What is ACX Therapeutics?
ACX Therapeutics develops synthetic compounds that mimic bacterial agents to combat microbes, targeting therapeutic applications in humans, animals, and crops.
Founded
2024
Investors
- Y Combinator
- TRIREC
- Mubadala Investment Company PJSC
YC Batch
S24
Product Features & Capabilities
- High specificity therapeutic compounds, advanced drug delivery systems, scalable and stable platform solution, targeted therapies for cancer and agriculture, environmentally friendly pest control measures.
See something that needs updating? Suggest edits to this profile.